Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

249420.KS


Top 10 Correlated ETFs

249420.KS


Top 10 Correlated Stocks

249420.KS


Financial details

Company Rating
Buy
Market Cap
1000.43B
Income
-181.37B
Revenue
628.48B
Book val./share
8681.21
Cash/share
3729.7
Dividend
-
Dividend %
-
Employees
1.41K
Optionable
No
Shortable
Yes
Earnings
-
P/E
-5.89
Forward P/E
-
PEG
-0.2
P/S
1.7
P/B
4.6
P/C
10.7
P/FCF
-16.45
Quick Ratio
0.31
Current Ratio
0.99
Debt / Equity
0.21
LT Debt / Equity
0.21
-
-
EPS (TTM)
-2.19K
EPS next Y
-
EPS next Q
-
EPS this Y
480.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.99%
Revenue Q/Q
0.7%
EPS Q/Q
-230.47%
-
-
-
-
SMA20
41.06%
SMA50
14.42%
SMA100
27.46%
Inst Own
-
Inst Trans
-
ROA
-25%
ROE
-87%
ROC
-0.17%
Gross Margin
37%
Oper. Margin
-11%
Profit Margin
-29%
Payout
-
Shs Outstand
26.79M
Shs Float
15.93M
-
-
-
-
Target Price
-
52W Range
16150.0-79500.0
52W High
-49.81%
52W Low
+147.06%
RSI
61.45
Rel Volume
3.59
Avg Volume
1.09M
Volume
3.93M
Perf Week
-3.86%
Perf Month
49.44%
Perf Quarter
-7.75%
Perf Half Y
-4.32%
-
-
-
-
Beta
1.09667
-
-
Volatility
1872.14%, 5265.65%
Prev Close
6.83%
Price
39900
Change
4.04%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
21.29K22.24K21.75K017.83K
Net income per share
917.15561.36-565.080-3.17K
Operating cash flow per share
3.41K2.94K1.74K814.15-361.73
Free cash flow per share
1.33K2.02K925.256.74-991.57
Cash per share
1.86K3.43K3.81K3.62K4.92K
Book value per share
13.18K12.22K10.63K10.7K4.87K
Tangible book value per share
8.56K8.33K7.7K8.05K2.99K
Share holders equity per share
13.18K12.22K10.63K10.7K4.87K
Interest debt per share
6.2K5.91K7.19K7.01K7.53K
Market cap
544.51B425.16B365.92B440.05B1013.33B
Enterprise value
634.97B479.62B441.88B521.34B1103.9B
P/E ratio
27.4433.42-27.220-10.16
Price to sales ratio
1.180.840.7101.81
POCF ratio
7.396.388.8522.72-89.15
PFCF ratio
18.869.2716.622.75K-32.52
P/B Ratio
1.911.541.451.736.63
PTB ratio
1.911.541.451.736.63
EV to sales
1.380.950.8501.97
Enterprise value over EBITDA
14.910.9942.040-11.03
EV to operating cash flow
8.617.210.6826.92-97.12
EV to free cash flow
21.9910.4620.073.25K-35.43
Earnings yield
0.040.03-0.040-0.1
Free cash flow yield
0.050.110.060-0.03
Debt to equity
0.160.130.220.290.6
Debt to assets
0.50.510.590.580.77
Net debt to EBITDA
2.121.257.230-0.91
Current ratio
1.31.291.11.260.83
Interest coverage
6.767.9-0.260-5.15
Income quality
3.725.24-3.0800.11
Dividend Yield
0.010.020.0200
Payout ratio
0.270.62-0.6400
Sales general and administrative to revenue
0.040.030.0300.02
Research and developement to revenue
0.070.090.0900.17
Intangibles to total assets
0.180.160.110.10.09
Capex to operating cash flow
-0.61-0.31-0.47-0.991.74
Capex to revenue
-0.1-0.04-0.040-0.04
Capex to depreciation
-2.43-0.88-0.69-0.69-0.68
Stock based compensation to revenue
00000
Graham number
16.49K12.42K11.63K018.64K
ROIC
0.060.0700-0.16
Return on tangible assets
0.040.03-0.020-0.16
Graham Net
-9.67K-8.1K-9.85K-9.25K-11.22K
Working capital
47.61B47.56B21.52B48.23B-62.59B
Tangible asset value
185.21B188.66B183.28B191.48B93.96B
Net current asset value
-74.53B-77.39B-126.46B-117.49B-246.84B
Invested capital
0.460.470.660.661.48
Average receivables
00000
Average payables
31.38B28.29B37.88B35.99B37.16B
Average inventory
74.61B71.21B79.49B89.23B85.91B
Days sales outstanding
00000
Days payables outstanding
41.6930.250.91041.07
Days of inventory on hand
93.478.0689.29088.48
Receivables turnover
00000
Payables turnover
8.7512.097.1708.89
Inventory turnover
3.914.684.0904.13
ROE
0.070.05-0.050-0.65
Capex per share
-2.07K-917.47-813.5-807.41-629.84

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
01.36K1.52K1.54K6.11K
Net income per share
0-890.89-1.15K479.79-626
Operating cash flow per share
228.23-85.92-108.96-70.79-755.79
Free cash flow per share
-95.72-115.72-143.02-112.82-966.53
Cash per share
6.83K1.47K003.73K
Book value per share
10.21K1.45K1.9K2.37K8.68K
Tangible book value per share
7.61K8931.97K2.43K6.53K
Share holders equity per share
10.21K1.45K1.9K2.37K8.68K
Interest debt per share
9.44K2.18K-1.11K891.937.32K
Market cap
330.62B3535.26B7175.73B3245.91B750.14B
Enterprise value
411.82B3625.83B7175.73B3245.91B880.28B
P/E ratio
0-9.43-14.7816.07-11.18
Price to sales ratio
024.7744.9519.984.58
POCF ratio
60.9-391.04-625.92-435.77-37.05
PFCF ratio
-145.22-290.34-476.87-273.44-28.97
P/B Ratio
1.3623.1235.8613.043.23
PTB ratio
1.3623.1235.8613.043.23
EV to sales
025.4144.9519.985.38
Enterprise value over EBITDA
0-31.16-30.3119.76-66.02
EV to operating cash flow
75.86-401.06-625.92-435.77-43.47
EV to free cash flow
-180.89-297.78-476.87-273.44-34
Earnings yield
0-0.03-0.020.02-0.02
Free cash flow yield
-0.01000-0.03
Debt to equity
0.450.6000.21
Debt to assets
0.640.770.710.650.67
Net debt to EBITDA
0-0.7800-9.76
Current ratio
1.350.830.911.140.99
Interest coverage
0-6.040.08-0.24-8.33
Income quality
00.10.09-0.151.21
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.020.430.510.02
Research and developement to revenue
00.21000.17
Intangibles to total assets
0.10.09000.09
Capex to operating cash flow
-1.420.350.310.590.28
Capex to revenue
0-0.02-0.02-0.03-0.03
Capex to depreciation
-1.04-0.42-0.49-0.61-0.78
Stock based compensation to revenue
00000
Graham number
05.4K7.03K5.05K11.06K
ROIC
0-0.05-0.02-0.05-0.05
Return on tangible assets
0-0.15-0.170.07-0.03
Graham Net
-10.12K-3.35K-4.86K-4.55K-12.17K
Working capital
81.65B-62.59B-29.62B43.58B-2.91B
Tangible asset value
181.03B93.96B00174.92B
Net current asset value
-132.48B-246.84B-200.11B-131.4B-157.73B
Invested capital
0.921.48000.83
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
038.20043.98
Days of inventory on hand
082.290087.26
Receivables turnover
00000
Payables turnover
02.36002.05
Inventory turnover
01.09001.03
ROE
0-0.61-0.610.2-0.07
Capex per share
-323.94-29.8-34.05-42.03-210.74

Frequently Asked Questions

What is Ildong Pharmaceutical Co., Ltd. stock symbol ?

Ildong Pharmaceutical Co., Ltd. is a US stock and trading under the symbol 249420.KS

What is Ildong Pharmaceutical Co., Ltd. stock quote today ?

Ildong Pharmaceutical Co., Ltd. stock price is $39900 today.

Is Ildong Pharmaceutical Co., Ltd. stock public?

Yes, Ildong Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap